ARCHIVES

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

Edelson To Step Down As Yale Center Director.

January 11, 2008

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive

May 10, 1996

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

Schweiker Approves Chabner Appointment

September 10, 1982